Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
Sage Therapeutics Stock Eyes Best Day In 5 Years On Biogen’s Unsolicited Bid: Retail Piles In
Via Stocktwits
Exposures Product Safety
Tickers BIIB SAGE
What's Going On With 22nd Century Group Shares Monday?
Via Benzinga
Exposures Product Safety
Tickers XXII
BNI Clinics Explains TMS’s Safety for Adolescents
Via Press Advantage
Exposures Product Safety
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Highlights 2024 Achievements and Outlines Key 2025 Milestones
Via Investor Brand Network
Exposures Product Safety
Tickers CYBN
Investor Workshop at Mar-A-Lago, $27 Million for Acquisitions and Drug Treatment of Suicidal Depression: NRx Pharmaceuticals, Inc. (Stock S: NRXP)
Via PRLog
Topics Bonds
Exposures Debt Markets Product Safety
Actuated Medical President & CEO Appointed as Chair of the Industrial Advisory Board for the Penn State Center for Biodevices
Via PRLog
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Adaptimmune Announces U.S. FDA Breakthrough Therapy Designation Granted to Letetresgene Autoleucel (lete-cel) for Treatment of Myxoid/Round Cell Liposarcoma (MRCLS)
Via Newsfile
Exposures Product Safety
Tickers ADAP JPM
Tesla Recalls Over 239,000 Vehicles, Uber and Lyft Revamp Robotaxi Strategy, Warren Buffett-Backed BYD Launches Affordable EV And More: This Week In Mobility
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers BRK BYDDF LYFT TSLA
Kessler Topaz Meltzer & Check, LLP Reminds APLT Investors of February 18, 2025 Deadline in Securities Fraud Class Action and Urges Investors With Losses to Contact the Firm
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Kessler Topaz Meltzer &amp; Check, LLP Reminds APLT Investors of February 18, 2025 Deadline in Securities Fraud Class Action and Urges Investors With Losses to Contact the Firm
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
XRAY Announcement: Contact Kessler Topaz Meltzer &amp; Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DENTSPLY SIRONA Inc.
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
XRAY Announcement: Contact Kessler Topaz Meltzer & Check, LLP About the Securities Fraud Class Action Lawsuit Filed Against DENTSPLY SIRONA Inc.
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Via Benzinga
Exposures Product Safety
Glafabra Therapeutics and University of Utah Announce Intent to Collaborate on Clinical Investigation for Fabry Disease
Via Newsworthy
Exposures Product Safety
Copperprotek, The First Packaging Copper-Salts-Based Shelf Life Extension Additive, Announces FDA/FSIS Clearance
Via Newsfile
Exposures Product Safety
Kessler Topaz Meltzer & Check, LLP Reminds XRAY Investors of January 27, 2025 Deadline in Securities Fraud Class Action and Urges Investors With Losses to Contact the Firm
Via NewMediaWire
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
Kessler Topaz Meltzer &amp; Check, LLP Reminds XRAY Investors of January 27, 2025 Deadline in Securities Fraud Class Action and Urges Investors With Losses to Contact the Firm
Via TheNewswire.com
Topics Fraud Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
Why Is Cancer-Focused Mersana Therapeutics Stock Trading Lower On Friday?
Via Benzinga
Exposures Product Safety
Tickers MRSN
Tesla Recalls 239,382 Vehicles In US Over Rearview Camera Image Display Issues
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
Zymeworks in Focus for Insider Activity: Catalysts Ahead
Via MarketBeat
Exposures Product Safety
Tickers WFC ZYME
Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening
Via Newsfile
Exposures Product Safety
Tickers CSE:IZO IZOZF
Solid Biosciences Outpaces Competitors In Duchenne Gene Therapy Development
Via Benzinga
Exposures Product Safety
Tickers NVS SLDB SRPT
Kessler Topaz Meltzer & Check, LLP Encourages DENTSPLY SIRONA Inc. Investors With Losses to Contact the Firm
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
Kessler Topaz Meltzer &amp; Check, LLP Encourages DENTSPLY SIRONA Inc. Investors With Losses to Contact the Firm
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers XRAY
Applied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer & Check, LLP
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Applied Therapeutics, Inc. (APLT) Investors: February 18, 2025 Filing Deadline in Securities Class Action - Contact Kessler Topaz Meltzer &amp; Check, LLP
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers APLT
Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder
Via Benzinga
Exposures Product Safety
Tickers GSK PFE
InvestorNewsBreaks – Silo Pharma Inc. (NASDAQ: SILO) Strengthens Patent Portfolio with Approval for PTSD Treatment SPC-15
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers SILO
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Appoints Gary Ainsworth as Vice President, Market Access
Via Investor Brand Network
Exposures Product Safety
Tickers TNXP
Invite God to Family Table with Louise Bonner’s Heartwarming New Children’s Book “Mum, Is God Coming to Dinner?”
Via Get News
Topics Product Recall
Exposures Legal Product Safety
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.